COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
Search
Commits to Thoracic Society’s COVID-19 Fund
Boehringer Ingelheim is committing USD 500,000 (around EUR 458,000) to the American Thoracic Society (ATS) and its COVID-19 Crisis Fund. Learn more here.
COVID-19 Czech Republic – Supporting hospitals, hippotherapy
We decided to support local Czech hospitals with a donation of 1.15 million CZK (42.000 EURO) to help them fight COVID-19. Click here to learn more.
COVID-19 France Support to Pasteur Institute
As part of our Global Donation Program, we are supporting research on COVID-19 in France. Click here to learn more information about the support.
COVID-19 Spain - Volunteering for good causes in Spain
Three Boehringer Ingelheim employees in Spain have stepped forward to help out during the COVID-19 pandemic. Click here to find out and learn more.
COVID-19 Once a nurse always a nurse
Colleagues Anne Hunstad and Maarten van Helvoirt, both educated nurses, support the health care workers during the COVID-19 pandemic. Learn more.
COVID-19 Joining forces against COVID-19
While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
COVID-19 Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.
COVID-19 Protecting Our Employees
We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
COVID-19 Boehringer Ingelheim Thailand equips frontline
Boehringer Ingelheim Thailand is working together with the Thai Department of Disease Control during the pandemic. Click here to learn more.
COVID-19 Italy for isolated patients to keep contact
300 tablets donated to hospitals in Italy where patients isolated due to COVID-19 are fighting for recovery to let them feel less alone. Learn more here.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.
COVID-19 Relief Efforts in China
Since the outbreak of the Coronavirus disease in China in late January, Boehringer Ingelheim has quickly decided to make a number of donations. Read more.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.
COVID-19 Social distancing and pet care - A vet gives advice
We have asked Karsten Hesse, Technical Service Manager Pet at Boehringer Ingelheim from Germany, about the topic of social distancing and pet care.
COVID-19 Spain pulse oximeters donation
Boehringer Ingelheim Spain has contributed to the COVIDALARM project by financing the purchase of 200 intelligent pulse oximeters. Learn more here.
COVID-19: EFPIA Industry Information
The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
COVID-19 Volunteering in India
Learn about our employees in India volunteering during COVID-19, including Rashmi Suvarna, Head of Procurement at Boehringer Ingelheim India.
COVID-19 Ivermectin Animal Health Not for Human Use
BI manufactures several veterinary products containing ivermectin. They are not approved or suitable for use in humans to try to prevent or treat COVID-19.
Healthcare professionals
Faced with COVID-19, everyone has to adjust their lives, which can be challenging. This is especially true for healthcare professionals. Find out more.
COVID-19 IMI2–Call 21
CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
Science against COVID-19 fake news and misinformation
As there is no evidence that animals can transmit COVID-19, the livestock community highlights information to join the battle against false claims.
COVID-19 Q&A for people with chronic respiratory conditions
Here you can find a summary of COVID-19 advice for those with chronic respiratory conditions. Click here to read the questions and answers and learn more.
COVID-19 Q&A for people with diabetes
Here you can find a summary of COVID-19 advice for patients with diabetes. Click here to read the questions and answers to find out more information.